Sudeep Pharma IPO Subscription Status
Sudeep Pharma IPO subscribed over 1.43x on its first day till 5.00 PM on November 21, 2025.
- Sudeep Pharma IPO subscription QIB investors’ portion is 0.09 times, while NII subscribed 3.01 times, and RII investors subscribed 1.52 times.
- The company has received bids for 1,50,97,250 shares against 1,05,64,927 shares on offer on the first day of subscription.
- Sudeep Pharma IPO subscribed over 1.43x on day 1.
About Sudeep Pharma Company
Sudeep Pharma Limited, founded in 1989, is one of the leading manufacturers of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. They aim to support the global healthcare ecosystem by serving their product to over 100 countries and supplying more than 200 products. To support innovation in their work, they use their own in-house technologies for encapsulation, spray drying, granulation, trituration, liposomal preparations, and mixing.
Their business is basically structured into 2 verticals: 1) Pharmaceutical, food, and nutrition, which includes key mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, and 2) Specialty Ingredients includes micronutrient premixes, encapsulated ingredients, granulated minerals, and triturated blends. Moreover, Sudeep Pharma runs six manufacturing facilities with a total production capacity of 50,000 MT.
Sudeep Pharma IPO GMP:
Sudeep Pharma’s IPO GMP was ₹118 as of Friday, November 21, 2025. That indicates the IPO is trading at ₹711 with a ₹118 premium in the grey market against the issue price of ₹593.
